Loading clinical trials...
Loading clinical trials...
A Multi-center, Randomized, Double-blind, Placebo-controlled Trial of Topical Ketotifen Fumarate 0.25% Cream for Females With Secondary Vestibulodynia
Conditions
Interventions
Ketotifen Fumarate 0.25% Cream
Placebo (Vehicle Cream)
Locations
3
United States
The Center for Vulvovaginal Disorders - Washington, DC
Washington D.C., District of Columbia, United States
The Center for Vulvovaginal Disorders
Tampa, Florida, United States
The Center for Vulvovaginal Disorders - New York
New York, New York, United States
Start Date
January 2, 2026
Primary Completion Date
August 1, 2026
Completion Date
January 1, 2027
Last Updated
March 18, 2026
NCT01829204
NCT05955313
NCT06472765
NCT05909514
NCT04461210
NCT05518630
Lead Sponsor
Center for Vulvovaginal Disorders
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions